Conley, Anthony P.
Roland, Christina L.
Bessudo, Alberto
Gastman, Brian R.
Villaflor, Victoria M.
Larson, Christopher
Reid, Tony R.
Caroen, Scott
Oronsky, Bryan http://orcid.org/0000-0002-3940-6329
Stirn, Meaghan
Williams, Jeannie
Burbano, Erica
Coyle, Angelique
Barve, Minal A.
Wagle, Naveed
Abrouk, Nacer
Kesari, Santosh
Funding for this research was provided by:
EpicentRx
Article History
Received: 24 May 2023
Revised: 30 November 2023
Accepted: 12 December 2023
First Online: 25 December 2023
Competing interests
: CL, TRR, SC, BO, MS, JW, EB, and AC report employment with and ownership of EpicentRx Inc. stock. No disclosures were reported by the other authors.
: The study was carried out with the approval of the Institutional Ethics committee of all participating institutions. The study was conducted in accordance with the ethical principles pronounced in the Declaration of Helsinki (Amendment 64th of the World Medical Association General Assembly, Fortaleza, Brazil, October 2013). This study is registered at the US Government ClinicalTrials.gov database as number NCT04673942. A signed informed consent was obtained from each participant prior to any study procedure.